Home Assessment of the fetal thymic-thoracic ratio in pregnant women with intrahepatic cholestasis: a prospective case-control study
Article
Licensed
Unlicensed Requires Authentication

Assessment of the fetal thymic-thoracic ratio in pregnant women with intrahepatic cholestasis: a prospective case-control study

  • Zahid Agaoglu ORCID logo EMAIL logo , Atakan Tanacan ORCID logo , Burcu Bozkurt Ozdal , Ezgi Basaran , Hakkı Serbetci , Merve Ozturk Agaoglu ORCID logo , Gulcan Okutucu ORCID logo , Ozgur Kara and Dilek Sahin
Published/Copyright: June 19, 2024

Abstract

Objectives

To examine the fetal thymic-thoracic ratio (TTR) in intrahepatic cholestasis of pregnancy (ICP).

Methods

This prospective case-control study was conducted in a single tertiary center. The sample consisted of 86 pregnant women at 28–37 weeks of gestation, including 43 women with ICP and 43 healthy controls. TTR was calculated for each patient using the anterior-posterior measurements of the thymus and intrathoracic mediastinal measurements.

Results

The median TTR value was found to be smaller in the ICP group compared to the control group (0.32 vs. 0.36, p<0.001). The ICP group had a greater rate of admission to the neonatal intensive care unit (NICU) (p<0.001). Univariate regression analysis revealed that lower TTR values increased the possibility of NICU admission six times (95 % confidence interval: 0.26–0.39, p=0.01). A statistically significant negative correlation was detected between TTR and the NICU requirement (r: −0.435, p=0.004). As a result of the receiver operating characteristic analysis, in predicting NICU admission, the optimal cut-off value of TTR was determined to be 0.31 with 78 % sensitivity and 67 % specificity (area under the curve=0.819; p<0.001).

Conclusions

We determined that the fetal TTR may be affected by the inflammatory process caused by the maternal-fetal immune system and increased serum bile acid levels in fetal organs in the presence of ICP. We consider that TTR can be used to predict adverse pregnancy outcomes in patients with ICP.


Corresponding Author: Zahid Agaoglu, MD, Maternal Fetal Specialist, Department of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Universiteler Mahallesi Bilkent Cad. No: 1, Cankaya 06800, Ankara, Türkiye, E-mail:

  1. Research ethics: Approval for the study was obtained from the Ethics Committee of the hospital (number: E2-23-4051). The principles of the Declaration of Helsinki were followed at every stage of the study.

  2. Informed consent: Informed consent was provided by each patient included in the study.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. ZA: Conceptualization, Methodology, Drafting the article, Supervision, Visualization. AT: Conceptualization, Investigation, Drafting the article, Methodology, Visualization. BBO: Investigation, Data curation, Drafting the article, Visualization, Formal Analysis. EB: Data curation, Visualization, Writing – original draft. HS: Data curation, Formal Analysis, Drafting the article. MOA: Investigation, Data curation, Drafting the article, Formal Analysis. GO: Data curation, Visualization, Drafting the article. OK: Analysis and interpretation of data, Validation, Visualization, Writing – review & editing. DS: Analysis and interpretation of data, Validation, Visualization, Writing – review & editing.

  4. Competing interests: The authors state no conflicts of interest.

  5. Research funding: None declared.

  6. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Girling, J, Knight, CL, Chappell, L. Intrahepatic cholestasis of pregnancy: green-top guideline no. 43 June 2022. BJOG 2022;129:e95–114. https://doi.org/10.1111/1471-0528.17206.Search in Google Scholar PubMed

2. Brouwers, L, Koster, MP, Page-Christiaens, GC, Kemperman, H, Boon, J, Evers, IM, et al.. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015;212:100.e1–7. https://doi.org/10.1016/j.ajog.2014.07.026.Search in Google Scholar PubMed

3. Bicocca, MJ, Sperling, JD, Chauhan, SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 2018;231:180–7. https://doi.org/10.1016/j.ejogrb.2018.10.041.Search in Google Scholar PubMed

4. Larson, SP, Kovilam, O, Agrawal, DK. Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy. Expet Rev Clin Immunol 2016;12:39–48. https://doi.org/10.1586/1744666x.2016.1101344.Search in Google Scholar PubMed PubMed Central

5. Kirbas, A, Biberoglu, E, Ersoy, AO, Dikmen, AU, Koca, C, Erdinc, S, et al.. The role of interleukin-17 in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med 2016;29:977–81. https://doi.org/10.3109/14767058.2015.1028354.Search in Google Scholar PubMed

6. Yousefzadeh, Y, Soltani-Zangbar, MS, Hemmatzadeh, M, Shomali, N, Mahmoodpoor, A, Ahmadian Heris, J, et al.. Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans. Immunol Invest 2022;51:1108–25. https://doi.org/10.1080/08820139.2021.1909061.Search in Google Scholar PubMed

7. Yayi, H, Danqing, W, Shuyun, L, Jicheng, L. Immunologic abnormality of intrahepatic cholestasis of pregnancy. Am J Reprod Immunol 2010;63:267–73. https://doi.org/10.1111/j.1600-0897.2009.00798.x.Search in Google Scholar PubMed

8. Pongcharoen, S, Searle, RF, Bulmer, JN. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Placenta 2004;25:321–30. https://doi.org/10.1016/j.placenta.2003.08.020.Search in Google Scholar PubMed

9. Zhang, Y, Liu, Z, Sun, H. Fetal-maternal interactions during pregnancy: a ‘three-in-one’ perspective. Front Immunol 2023;14:1198430. https://doi.org/10.3389/fimmu.2023.1198430.Search in Google Scholar PubMed PubMed Central

10. Yang, F, Zheng, Q, Jin, L. Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface. Front Immunol 2019;10:2317. https://doi.org/10.3389/fimmu.2019.02317.Search in Google Scholar PubMed PubMed Central

11. Di Mascio, D, Quist-Nelson, J, Riegel, M, George, B, Saccone, G, Brun, R, et al.. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. J Matern Fetal Neonatal Med 2021;34:3614–22. https://doi.org/10.1080/14767058.2019.1685965.Search in Google Scholar PubMed

12. Majsterek, M, Wierzchowska-Opoka, M, Makosz, I, Kreczyńska, L, Kimber-Trojnar, Ż, Leszczyńska-Gorzelak, B. Bile acids in intrahepatic cholestasis of pregnancy. Diagnostics 2022;12:1–13. https://doi.org/10.3390/diagnostics12112746.Search in Google Scholar PubMed PubMed Central

13. Farley, AM, Morris, LX, Vroegindeweij, E, Depreter, ML, Vaidya, H, Stenhouse, FH, et al.. Dynamics of thymus organogenesis and colonization in early human development. Development 2013;140:2015–26. https://doi.org/10.1242/dev.087320.Search in Google Scholar PubMed PubMed Central

14. Chaoui, R, Heling, KS, Lopez, AS, Thiel, G, Karl, K. The thymic-thoracic ratio in fetal heart defects: a simple way to identify fetuses at high risk for microdeletion 22q11. Ultrasound Obstet Gynecol 2011;37:397–403. https://doi.org/10.1002/uog.8952.Search in Google Scholar PubMed

15. Dörnemann, R, Koch, R, Möllmann, U, Falkenberg, MK, Möllers, M, Klockenbusch, W, et al.. Fetal thymus size in pregnant women with diabetic diseases. J Perinat Med 2017;45:595–601. https://doi.org/10.1515/jpm-2016-0400.Search in Google Scholar PubMed

16. Porschen, C, Schmitz, R, Schmidt, R, Oelmeier, K, Hammer, K, Falkenberg, M, et al.. Second trimester fetal thymus size in association to preterm birth. J Perinat Med 2022;50:144–9. https://doi.org/10.1515/jpm-2021-0065.Search in Google Scholar PubMed

17. Gök, K, Ozden, S. Ultrasonographic evaluation of the fetal thymic-thoracic ratio in preeclampsia. J Matern Fetal Neonatal Med 2023;36:2183739. https://doi.org/10.1080/14767058.2023.2183739.Search in Google Scholar PubMed

18. Vigneswaran, TV, Kametas, NA, Zinevich, Y, Bataeva, R, Allan, LD, Zidere, V. Assessment of cardiac angle in fetuses with congenital heart disease at risk of 22q11.2 deletion. Ultrasound Obstet Gynecol 2015;46:695–9. https://doi.org/10.1002/uog.14832.Search in Google Scholar PubMed

19. Bhide, A, Acharya, G, Baschat, A, Bilardo, CM, Brezinka, C, Cafici, D, et al.. ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics. Ultrasound Obstet Gynecol 2021;58:331–9. https://doi.org/10.1002/uog.23698.Search in Google Scholar PubMed

20. Li, L, Bahtiyar, MO, Buhimschi, CS, Zou, L, Zhou, QC, Copel, JA. Assessment of the fetal thymus by two- and three-dimensional ultrasound during normal human gestation and in fetuses with congenital heart defects. Ultrasound Obstet Gynecol 2011;37:404–9. https://doi.org/10.1002/uog.8853.Search in Google Scholar PubMed

21. Mohamed, N, Eviston, DP, Quinton, AE, Benzie, RJ, Kirby, AC, Peek, MJ, et al.. Smaller fetal thymuses in pre-eclampsia: a prospective cross-sectional study. Ultrasound Obstet Gynecol 2011;37:410–5. https://doi.org/10.1002/uog.8953.Search in Google Scholar PubMed

22. Gamez, F, De Leon-Luis, J, Pintado, P, Perez, R, Robinson, JN, Antolin, E, et al.. Fetal thymus size in uncomplicated twin and singleton pregnancies. Ultrasound Obstet Gynecol 2010;36:302–7. https://doi.org/10.1002/uog.7578.Search in Google Scholar PubMed

23. Yinon, Y, Zalel, Y, Weisz, B, Mazaki-Tovi, S, Sivan, E, Schiff, E, et al.. Fetal thymus size as a predictor of chorioamnionitis in women with preterm premature rupture of membranes. Ultrasound Obstet Gynecol 2007;29:639–43. https://doi.org/10.1002/uog.4022.Search in Google Scholar PubMed

24. Aksakal, SE, Kandemir, O, Altınbas, S, Esin, S, Muftuoglu, KH. Fetal tyhmus size as a predictor of histological chorioamnionitis in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2014;27:1118–22. https://doi.org/10.3109/14767058.2013.850666.Search in Google Scholar PubMed

25. Ekin, A, Gezer, C, Taner, CE, Solmaz, U, Gezer, NS, Ozeren, M. Prognostic value of fetal thymus size in intrauterine growth restriction. J Ultrasound Med 2016;35:511–7. https://doi.org/10.7863/ultra.15.05039.Search in Google Scholar PubMed

26. Di Naro, E, Cromi, A, Ghezzi, F, Raio, L, Uccella, S, D’Addario, V, et al.. Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am J Obstet Gynecol 2006;194:153–9. https://doi.org/10.1016/j.ajog.2005.05.036.Search in Google Scholar PubMed

27. Yildirim, M, Oluklu, D, Menekse Beser, D, Uyan Hendem, D, Kara, O, Tanacan, A, et al.. Assessment of fetal thymus size in pregnant women with rheumatic diseases: a case-control study. J Clin Ultrasound 2023;51:1342–7. https://doi.org/10.1002/jcu.23532.Search in Google Scholar PubMed

28. Beser, DM, Oluklu, D, Hendem, DU, Yıldırım, M, Tanacan, A, Sahın, D. Fetal thymic-thoracic ratio in pregnancies with familial Mediterranean fever. Eur J Obstet Gynecol Reprod Biol 2023;282:105–9. https://doi.org/10.1016/j.ejogrb.2023.01.017.Search in Google Scholar PubMed

29. Karl, K, Heling, KS, Sarut Lopez, A, Thiel, G, Chaoui, R. Thymic-thoracic ratio in fetuses with trisomy 21, 18 or 13. Ultrasound Obstet Gynecol 2012;40:412–7. https://doi.org/10.1002/uog.11068.Search in Google Scholar PubMed

30. Monteiro, M, Aires, T, Pimentel, K, Pedrosa, K, Lima, S, Aquino, M, et al.. Ultrasonographic evaluation of the fetal thymic-thoracic ratio and its association with conotruncal heart defects. J Gynecol Obstet Hum Reprod 2022;51:102281. https://doi.org/10.1016/j.jogoh.2021.102281.Search in Google Scholar PubMed

Received: 2024-04-26
Accepted: 2024-05-27
Published Online: 2024-06-19
Published in Print: 2024-09-25

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Corner of Academy
  3. The IAPM New York 2024 declaration on professional responsibility and abortion
  4. Review
  5. Common foot and ankle disorders in pregnancy: the role of diagnostic ultrasound
  6. Opinion Paper
  7. Reproductive genetic carrier screening in pregnancy: improving health outcomes and expanding access
  8. Original Articles – Obstetrics
  9. “It feels like you have to choose one or the other”: a qualitative analysis of obstetrician focus groups on periviability counseling
  10. Expectant management vs. cerclage in cases with prolapsed or visible membranes in the second trimester: is 24 weeks gestation threshold critical?
  11. Prevention of preterm birth in twin-to-twin transfusion syndrome: a systematic review and network meta-analysis
  12. Accidental uterine extensions in cesarean deliveries – outcome of subsequent pregnancy
  13. Effect of acidic vaginal pH on the efficacy of dinoprostone (PGE2) vaginal tablet for labor induction in full term pregnant women: a randomized controlled trial
  14. Oligohydramnios at term in the high-risk population – how severe is severe?
  15. Original Articles – Fetus
  16. Assessment of the fetal thymic-thoracic ratio in pregnant women with intrahepatic cholestasis: a prospective case-control study
  17. Congenital diaphragmatic hernia treated via fetal endoscopic tracheal occlusion improves outcome in a middle-income country
  18. Fetal bradyarrhythmias: classification, monitoring and outcomes of 40 cases at a single center
  19. Deep learning based detection and classification of fetal lip in ultrasound images
  20. Original Articles – Neonates
  21. Cytomegalovirus congenital infection: long-term outcomes in a valaciclovir treated population
  22. Does placental VEGF-A protein expression predict early neurological outcome of neonates from FGR complicated pregnancies?
  23. Letters to the Editor
  24. Why do women choose home births: correspondence
  25. Enhancing safety and outcomes in home births: a detailed response to concerns and recommendations
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2024-0191/html
Scroll to top button